Literature DB >> 20549359

High frequencies of biotinidase (BTD) gene mutations in the Hungarian population.

Ilona Milánkovics1, Krisztina Németh, Csilla Somogyi, Agnes Schuler, György Fekete.   

Abstract

Biotinidase deficiency, an autosomal recessively inherited disorder, is characterized by neurologic and cutaneous symptoms and can be detected by newborn screening. In Hungary the national screening programme was launched in 1989 with two screening centres. Over 1,070,000 neonates from western Hungary were screened for biotinidase deficiency in the Budapest Screening Centre between 1989 and December 2008. In this period, 57 patients with profound or partial biotinidase deficiency from 50 families were identified through routine newborn screening. The incidence of the disorder in western Hungary is 1 in 18,700, which is about three times the worldwide incidence. Twenty-four different mutations were identified in patients including the c.406delC novel mutation in exon 3, which is a frameshift mutation. To better understand the background of the unusually high disease incidence, 100 healthy subjects from the Hungarian population were screened by PCR and RFLP for the frequencies of p.D444H, p.Q456H and p.A171T;p.D444H, the three most common BTD mutations. The frequencies were found to be 5.5, 0.5 and 0%, respectively. The results demonstrate that the frequencies of two of the most common biotinidase variant alleles are higher in the Hungarian population than in other Caucasian populations. This and the presence of a unique Hungarian mutation may explain the high incidence of biotinidase deficiency in Hungary.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20549359     DOI: 10.1007/s10545-010-9152-0

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  22 in total

1.  Novel mutations cause biotinidase deficiency in Turkish children.

Authors:  R J Pomponio; T Coskun; M Demirkol; A Tokatli; I Ozalp; G Hüner; T Baykal; B Wolf
Journal:  J Inherit Metab Dis       Date:  2000-03       Impact factor: 4.982

2.  Molecular characterisation and neuropsychological outcome of 21 patients with profound biotinidase deficiency detected by newborn screening and family studies.

Authors:  Dorothea Möslinger; Adolf Mühl; Terttu Suormala; Regula Baumgartner; Sylvia Stöckler-Ipsiroglu
Journal:  Eur J Pediatr       Date:  2003-11-20       Impact factor: 3.183

3.  Worldwide survey of neonatal screening for biotinidase deficiency.

Authors:  B Wolf
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

4.  Double mutation (A171T and D444H) is a common cause of profound biotinidase deficiency in children ascertained by newborn screening the the United States. Mutations in brief no. 128. Online.

Authors:  K J Norrgard; R J Pomponio; K L Swango; J Hymes; T Reynolds; G A Buck; B Wolf
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

5.  Mutation (Q456H) is the most common cause of profound biotinidase deficiency in children ascertained by newborn screening in the United States.

Authors:  K J Norrgard; R J Pomponio; K L Swango; J Hymes; T R Reynolds; G A Buck; B Wolf
Journal:  Biochem Mol Med       Date:  1997-06

6.  Mutations causing biotinidase deficiency in children ascertained by newborn screening in Western Hungary.

Authors:  Ilona Milánkovics; Eniko Kámory; Béla Csókay; Flóra Fodor; Csilla Somogyi; Agnes Schuler
Journal:  Mol Genet Metab       Date:  2006-12-20       Impact factor: 4.797

7.  Structure of the human biotinidase gene.

Authors:  H C Knight; T R Reynolds; G A Meyers; R J Pomponio; G A Buck; B Wolf
Journal:  Mamm Genome       Date:  1998-04       Impact factor: 2.957

8.  Partial biotinidase deficiency is usually due to the D444H mutation in the biotinidase gene.

Authors:  K L Swango; M Demirkol; G Hüner; E Pronicka; J Sykut-Cegielska; A Schulze; E Mayatepek; B Wolf
Journal:  Hum Genet       Date:  1998-05       Impact factor: 4.132

9.  Localization of serum biotinidase (BTD) to human chromosome 3 in band p25.

Authors:  H Cole; S Weremowicz; C C Morton; B Wolf
Journal:  Genomics       Date:  1994-08       Impact factor: 5.736

10.  Biotinidase deficiency: initial clinical features and rapid diagnosis.

Authors:  B Wolf; G S Heard; K A Weissbecker; J R McVoy; R E Grier; R T Leshner
Journal:  Ann Neurol       Date:  1985-11       Impact factor: 10.422

View more
  3 in total

1.  Neonatal screening for profound biotinidase deficiency in the Netherlands: consequences and considerations.

Authors:  Rachel C Wiltink; Michelle E Kruijshaar; Rick van Minkelen; Willem Onkenhout; Frans W Verheijen; Evelien A Kemper; Francjan J van Spronsen; Ans T van der Ploeg; Klary E Niezen-Koning; Jasper J Saris; Monique Williams
Journal:  Eur J Hum Genet       Date:  2016-06-22       Impact factor: 4.246

2.  Molecular Background and Disease Prevalence of Biotinidase Deficiency in a Polish Population-Data Based on the National Newborn Screening Programme.

Authors:  Aleksandra Jezela-Stanek; Lidia Suchoń; Agnieszka Sobczyńska-Tomaszewska; Kamila Czerska; Katarzyna Kuśmierska; Joanna Taybert; Mariusz Ołtarzewski; Jolanta Sykut-Cegielska
Journal:  Genes (Basel)       Date:  2022-04-29       Impact factor: 4.141

3.  Biotinidase deficiency: clinical and genetic studies of 38 Brazilian patients.

Authors:  Taciane Borsatto; Fernanda Sperb-Ludwig; Louise L C Pinto; Gisele R De Luca; Francisca L Carvalho; Carolina F M De Souza; Paula F V De Medeiros; Charles M Lourenço; Reinaldo Lo Filho; Eurico C Neto; Pricila Bernardi; Sandra Leistner-Segal; Ida V Schwartz
Journal:  BMC Med Genet       Date:  2014-09-01       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.